ArticleAnnals of medicine2024

Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China.

Pengcheng Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.